- Home
- APLS vs FCFS Comparison
APLS vs FCFS Comparison
Compare APLS & FCFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- FCFS
- Stock Information
- Founded
- APLS 2009
- FCFS 1988
- Country
- APLS United States
- FCFS United States
- Employees
- APLS N/A
- FCFS N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- FCFS Other Specialty Stores
- Sector
- APLS Health Care
- FCFS Consumer Discretionary
- Exchange
- APLS Nasdaq
- FCFS Nasdaq
- Market Cap
- APLS 4.4B
- FCFS 4.7B
- IPO Year
- APLS 2017
- FCFS 1991
- Fundamental
- Price
- APLS $27.75
- FCFS $102.97
- Analyst Decision
- APLS Buy
- FCFS Strong Buy
- Analyst Count
- APLS 19
- FCFS 4
- Target Price
- APLS $49.89
- FCFS $135.67
- AVG Volume (30 Days)
- APLS 4.0M
- FCFS 318.1K
- Earning Date
- APLS 11-05-2024
- FCFS 10-24-2024
- Dividend Yield
- APLS N/A
- FCFS 1.47%
- EPS Growth
- APLS N/A
- FCFS 8.11
- EPS
- APLS N/A
- FCFS 5.41
- Revenue
- APLS $715,216,000.00
- FCFS $3,356,837,000.00
- Revenue This Year
- APLS $95.59
- FCFS $10.19
- Revenue Next Year
- APLS $13.77
- FCFS $5.07
- P/E Ratio
- APLS N/A
- FCFS $19.02
- Revenue Growth
- APLS 162.10
- FCFS 10.10
- 52 Week Low
- APLS $24.34
- FCFS $101.62
- 52 Week High
- APLS $73.80
- FCFS $133.64
- Technical
- Relative Strength Index (RSI)
- APLS 47.09
- FCFS 35.81
- Support Level
- APLS $25.76
- FCFS $105.26
- Resistance Level
- APLS $30.80
- FCFS $106.13
- Average True Range (ATR)
- APLS 1.84
- FCFS 2.93
- MACD
- APLS 0.04
- FCFS -0.15
- Stochastic Oscillator
- APLS 52.79
- FCFS 0.94
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About FCFS FirstCash Holdings Inc.
FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Close to 30% of total company revenue comes from interest earned on the loans. Close to 70% of total revenue comes from reselling forfeited property in the company's retail stores.